Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News GNI Group to halt enrolment in Phase 2 liver fibrosis trial following positive results Japanese biotech company GNI Group has announced it will cease enrolment of new patients in its Phase 2… bypharmanewsdailyOctober 2, 2018
